PMID- 24096030
OWN - NLM
STAT- MEDLINE
DCOM- 20140904
LR  - 20140210
IS  - 1549-9642 (Electronic)
IS  - 1549-9634 (Linking)
VI  - 10
IP  - 2
DP  - 2014 Feb
TI  - Anti-leishmanial activity of the antimicrobial peptide DRS 01 observed in Leishmania 
      infantum (syn. Leishmania chagasi) cells.
PG  - 483-90
LID - S1549-9634(13)00478-4 [pii]
LID - 10.1016/j.nano.2013.09.003 [doi]
AB  - Leishmaniasis is one of the most serious diseases in the world and can be lethal if 
      untreated. This is especially the case for visceral leishmaniasis, which is commonly 
      caused by Leishmania (L.) infantum and for which available medication is still 
      inadequate. A recently described antimicrobial peptide DRS 01 has been reported to 
      kill L. infantum promastigotes, but nothing is known about its mode of action or 
      effect on the cell. In this paper we report the visualization of the interaction 
      between DRS 01 and L. infantum promastigotes using two high resolution microscopic 
      techniques: atomic force microscopy and scanning electron microscopy. The results 
      show considerable morphological changes at and above the IC50 in the treated cells. 
      Both membrane damage and flagella alterations were observed. The results strongly 
      suggest a membrane-directed action for DRS 01 on the Leishmania species studied. 
      FROM THE CLINICAL EDITOR: In this paper, the effects of DRS 01, an antimicrobial 
      peptide, is studied in Leishmania infantum using atomic force microscopy as well as 
      standard scanning electron microscopy techniques, with the conclusion of a 
      membrane-based effect by DRS 01 on the parasites.
CI  - © 2014.
FAU - Eaton, Peter
AU  - Eaton P
AD  - REQUIMTE/Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade 
      do Porto, Rua do Campo Alegre, Porto, Portugal. Electronic address: 
      peter.eaton@fc.up.pt.
FAU - Bittencourt, Clícia R
AU  - Bittencourt CR
AD  - Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Campus de Parnaíba, 
      Universidade Federal do Piauí, UFPI, Parnaíba, PI, Brazil.
FAU - Costa Silva, Vladimir
AU  - Costa Silva V
AD  - Laboratório de Pesquisas em Leishmanioses, Instituto de Doenças Tropicais Natan 
      Portella, IDTNP, Teresina, Brazil.
FAU - Véras, Leiz M C
AU  - Véras LM
AD  - Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Campus de Parnaíba, 
      Universidade Federal do Piauí, UFPI, Parnaíba, PI, Brazil.
FAU - Costa, Carlos H N
AU  - Costa CH
AD  - Laboratório de Pesquisas em Leishmanioses, Instituto de Doenças Tropicais Natan 
      Portella, IDTNP, Teresina, Brazil.
FAU - Feio, Maria J
AU  - Feio MJ
AD  - REQUIMTE/Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade 
      do Porto, Rua do Campo Alegre, Porto, Portugal.
FAU - Leite, José Roberto S A
AU  - Leite JR
AD  - Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Campus de Parnaíba, 
      Universidade Federal do Piauí, UFPI, Parnaíba, PI, Brazil.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20131002
PL  - United States
TA  - Nanomedicine
JT  - Nanomedicine : nanotechnology, biology, and medicine
JID - 101233142
RN  - 0 (Amphibian Proteins)
RN  - 0 (Antimicrobial Cationic Peptides)
RN  - 0 (Antiprotozoal Agents)
RN  - 136212-91-4 (dermaseptin)
SB  - IM
MH  - Amphibian Proteins/*chemistry/isolation & purification
MH  - Animals
MH  - Antimicrobial Cationic Peptides/*chemistry/isolation & purification
MH  - Antiprotozoal Agents/*therapeutic use
MH  - Cell Membrane/parasitology
MH  - Flagella
MH  - Humans
MH  - Inhibitory Concentration 50
MH  - Leishmania infantum/*drug effects
MH  - Leishmaniasis, Visceral/*drug therapy/parasitology
OTO - NOTNLM
OT  - Atomic force microscopy
OT  - Dermaseptins
OT  - Leishmania chagasi
OT  - Leishmania infantum
OT  - Scanning electron microscopy
EDAT- 2013/10/08 06:00
MHDA- 2014/09/05 06:00
CRDT- 2013/10/08 06:00
PHST- 2013/05/21 00:00 [received]
PHST- 2013/07/08 00:00 [revised]
PHST- 2013/09/16 00:00 [accepted]
PHST- 2013/10/08 06:00 [entrez]
PHST- 2013/10/08 06:00 [pubmed]
PHST- 2014/09/05 06:00 [medline]
AID - S1549-9634(13)00478-4 [pii]
AID - 10.1016/j.nano.2013.09.003 [doi]
PST - ppublish
SO  - Nanomedicine. 2014 Feb;10(2):483-90. doi: 10.1016/j.nano.2013.09.003. Epub 2013 Oct 
      2.
